The high efficiency of the combined inhibition of c-MET and ILEI function on the inhibition of invasion and tumor growth of cancer cells bearing MET and FAM3C amplifications found in this study justifies the relevance of this co-amplification on clinical outcomes. The gene discussed is FAM3C; the disease is neoplasm.